Patients with RA have 2-2.5 times higher serum YKL-40 concentrations compared to healthy controls and positive correlation to disease activity, but together with IL-6 and vascular endothelial growth factor YKL-40 cannot predict clinical remission or radiographic progression in early RA (54, 78). Here, IL6 is linked to rheumatoid arthritis.